coldnewfie - As far as getting prepared for a US listing all of the accounting functions  were done some 2 years ago now at the latest. Sometimes it takes longer to close deals that have been expected. This is especially true if there is moving targets (Zenith having continued success) and potentially multiple purchasers to deal with. If memory serves me the Medivation deal took more than 8 months to officially be announced after the first rumours of a potential deal surfaced. It would be nice if we saw a $14 billion deal but I'm certainly not counting on that.

As far as why they continue to do financings of any size, the rule of thumb is to expect that any potential deal will not close and always be prepared to continue business. I would be concerned if they were not continuing with business as usual.

This little company closing in on the end of a phase III trial that doesn't have more than 100k shares trading; It is completely logical that there is not much trading. This company is, in my estimation is very tightly held. There may be 54 million shares in the float but very few actually trade. Most of the posters on this board seem to be accumulating shares rather than trading. Anyone who has followed this story is looking for a happy ending which we should know in about 4 1/2 months or less for the Top Line results and within a few weeks or months after that for the full data presentations.

IMO the commercial value of both companies increases the longer it takes to get to the end of their respective trials.

Hang in there man the end of this long journey is getting clearer each day.

All IMO, dyodd 

tada